2024 Chem Outsourcing Conference For Pharmaceutical Professionals

One-to-One Supplier – Rx Buyer Company Meetings

Breaking News

Now in its 3rd year, "Speed Dating" provides a casual forum for all attendees to meet with select pharmaceutical company personnel on Tues Sept 15 from 2-3pm in the exhibit halls.

In this business adaption of the popular activity "Speed Dating", suppliers are invited to visit pharma buyer hosted tables to make 3 minute introductions, then quickly rotate together to the next table at the sound of the bell.

At the end of the hour, participants tell me that they make valuable new contacts they would not have been able to otherwise.

Pharmaceutical company participants have already identified their interest areas (see below) so that they will be visited only by suppliers whose service offerings match their needs. Thus, no bad "dates"!

Several companies have elected to host multiple tables simultaneously to enable them to meet suppliers across the full spectrum of Drug Discovery, Development and API Commercialization suppliers.

It is my hope that this fast-paced and fun activity will increasingly provide a unique and valuable “dating” forum for the industry.

ChemOutsourcing is designed to foster easy mixing of attendees in the very serious endeavor of Business Development. It just got easier!

Mark Alexay
President
ChemOutsourcing

Pharmaceutical Company Participants & Service Need Profiles

TRACK A	TRACK B
Intrexon Corporation API Development Celgene Corporation Table #3 Technical Affairs Gilead Sciences No Suppler Profile Preference "We Prefer it to be a Spontaneous Event!" Eleison Pharmaceuticals Late Stage Anti-Cancer Drug Development API, DP Mfg., Release and Stability Testing Eli Lilly & Co API Development Pfizer, Inc. CRO/CMO, Development, Intermediates, APIs and Contract Manufacturing Blueprint Medicines Late Discovery Through Clinical Validation Chemistry, Formulation, Strong Analytical Novartis DS, Formulation Development and Manufacture, including Analytics Verastem Drug Substance, API, Development & Manufacturing of intermediates and cGMP API for oncology drug candidates Merck Table #2 Process Research & Development United Therapeutics Raw Materials/Starting Materials, Intermediates, Scale-Up, Analytical Method Development, Polymorph Screening Melinta Therapeutics API Development and Raw Materials Epizyme API & DP Development; Regulatory Strategies for Phase 1 Genentech High potent Small Molecule API & DP Clinical GMP manufacture High potent milling Amgen, Inc. TBD	Takeda Pharmaceuticals Medicinal Chemistry/Discovery Sumitomo Dainippon Pharma Co., Ltd. Medicinal Chemistry-Support Synthesis Services Pfizer Table #2 Discovery & Medicinal Chemistry Boehringer-Ingelheim Pharma Medicinal Chemistry/Discovery Celgene Corporation Table #1 Medicinal Chemistry/Discovery Dermira, Inc. Integrated Discovery-to-Phase I Capability No Pure-Play API or MedChem Celgene Corporation Table #2 Early Development Merck Table #1 Discovery/Medicinal Chemistry Receptos, Inc. GMP manufacturers with Process Development Capabilities Analytical Development Group and Stability Program AbbVie, Inc. Large volume GMP production with Containment Small Volume, Highly Potent GMP production API Solids Processing Regulatory Starting Materials Newron Pharmaceuticals CRO/CMOs for API, Drug Product, Analytical and Clinical Supply Chain Management. On API, Small Molecules and Biologics Sanofi-Aventis CRO/CMO; Process R&D ; Intermediates Everything for early clinical phases up to proof of concept Tolero Pharmaceuticals API and drug product CMOs Pre-IND to commercial phase appropriate development, including solid state API studies and QbD in support of process validation. X-Rx Discovery, Inc. Need CMO to scale up 40-100kg of API. Also need a new discovery focused CRO for early stage programs

TRACK A

TRACK B

Intrexon Corporation
API Development

Celgene Corporation Table #3
Technical Affairs

Gilead Sciences
No Suppler Profile Preference
"We Prefer it to be a Spontaneous Event!"

Eleison Pharmaceuticals
Late Stage Anti-Cancer Drug Development
API, DP Mfg., Release and Stability Testing

Eli Lilly & Co
API Development

Pfizer, Inc.
CRO/CMO, Development, Intermediates,
APIs and Contract Manufacturing

Blueprint Medicines
Late Discovery Through Clinical Validation
Chemistry, Formulation, Strong Analytical

Novartis
DS, Formulation Development and Manufacture,
including Analytics

Verastem
Drug Substance, API, Development & Manufacturing
of intermediates and cGMP API for oncology drug candidates

Merck Table #2
Process Research & Development

United Therapeutics
Raw Materials/Starting Materials, Intermediates,
Scale-Up, Analytical Method Development,
Polymorph Screening

Melinta Therapeutics
API Development and Raw Materials

Epizyme
API & DP Development; Regulatory Strategies for Phase 1

Genentech
High potent Small Molecule API & DP Clinical GMP manufacture
High potent milling

Amgen, Inc.
TBD

Takeda Pharmaceuticals
Medicinal Chemistry/Discovery

Sumitomo Dainippon Pharma Co., Ltd.
Medicinal Chemistry-Support Synthesis Services

Pfizer Table #2
Discovery & Medicinal Chemistry

Boehringer-Ingelheim Pharma
Medicinal Chemistry/Discovery

Celgene Corporation Table #1
Medicinal Chemistry/Discovery

Dermira, Inc.
Integrated Discovery-to-Phase I Capability
No Pure-Play API or MedChem

Celgene Corporation Table #2
Early Development

Merck Table #1
Discovery/Medicinal Chemistry

Receptos, Inc.
GMP manufacturers with Process Development Capabilities
Analytical Development Group and Stability Program

AbbVie, Inc.
Large volume GMP production with Containment
Small Volume, Highly Potent GMP production
API Solids Processing
Regulatory Starting Materials

Newron Pharmaceuticals
CRO/CMOs for API, Drug Product, Analytical and
Clinical Supply Chain Management. On API,
Small Molecules and Biologics

Sanofi-Aventis
CRO/CMO; Process R&D ; Intermediates
Everything for early clinical phases up to proof of concept

Tolero Pharmaceuticals
API and drug product CMOs Pre-IND to commercial
phase appropriate development, including solid state API
studies and QbD in support of process validation.

X-Rx Discovery, Inc.
Need CMO to scale up 40-100kg of API. Also need a new
discovery focused CRO for early stage programs